The increasing field of immunotherapy relies heavily on recombinant cytokine technology, and a detailed understanding of individual profiles is essential for optimizing experimental design and therapeutic efficacy. https://one-bookmark.com/story20875544/analyzing-recombinant-mediator-profiles-il-1a-il-1b-il-2-and-il-3